1. Home
  2. MHF vs VANI Comparison

MHF vs VANI Comparison

Compare MHF & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Municipal High Income Fund Inc.

MHF

Western Asset Municipal High Income Fund Inc.

HOLD

Current Price

$6.44

Market Cap

152.3M

Sector

Finance

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.24

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHF
VANI
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.3M
119.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MHF
VANI
Price
$6.44
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
60.8K
217.3K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
4.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.35
$0.92
52 Week High
$7.55
$1.92

Technical Indicators

Market Signals
Indicator
MHF
VANI
Relative Strength Index (RSI) 19.70 44.03
Support Level N/A $1.13
Resistance Level $7.04 $1.54
Average True Range (ATR) 0.09 0.07
MACD -0.03 -0.02
Stochastic Oscillator 12.50 24.64

Price Performance

Historical Comparison
MHF
VANI

About MHF Western Asset Municipal High Income Fund Inc.

Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: